Azaro, A.
184  Ergebnisse:
Personensuche X
?
4

Phase I/IIa, open-label, multicentre study to evaluate the ..:

Bono, P ; Massard, C ; Peltola, KJ...
https://discovery.ucl.ac.uk/id/eprint/10117425/1/e001081.full.pdf.  , 2020
 
?
5

Molecular correlates of response to capmatinib in advanced ..:

Schuler, M ; Berardi, R ; Lim, W.-T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720758/.  , 2020
 
?
6

Phase I/IIa, open-label, multicentre study to evaluate the ..:

Bono P ; Massard C ; Peltola K. J...
info:eu-repo/semantics/altIdentifier/pmid/33262202.  , 2020
 
?
7

Molecular correlates of response to capmatinib in advanced ..:

Schuler, M ; Berardi, R ; Lim, WT...
Schuler , M , Berardi , R , Lim , WT , de Jonge , M , Bauer , TM , Azaro , A , Gottfried , M , Han , JY , Lee , D H , Wollner , M , Hong , DS , Vogel , A , Delmonte , A , Akimov , M , Ghebremariam , S , Cui , X , Nwana , N , Giovannini , M & Kim , TM 2020 , ' Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial ' , Annals of Oncology , vol. 31 , no. 6 , pp. 789-797 . https://doi.org/10.1016/j.annonc.2020.03.293.  , 2020
 
?
8

First-in-human study of LY3039478, an oral Notch signaling ..:

Massard, C ; Azaro, A ; Soria, J. C...
Massard , C , Azaro , A , Soria , J C , Lassen , U , Le Tourneau , C , Sarker , D , Smith , C , Ohnmacht , U , Oakley , G , Patel , B K R , Yuen , E S M , Benhadji , K A & Rodon , J 2018 , ' First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer ' , Annals of Oncology , vol. 29 , no. 9 , pp. 1911-1917 . https://doi.org/10.1093/annonc/mdy244.  , 2018
 
?
9

First-in-human study of LY3039478, an oral Notch signaling ..:

Massard, C ; Azaro, A ; Soria, J. C...
Massard , C , Azaro , A , Soria , J C , Lassen , U , Le Tourneau , C , Sarker , D , Smith , C , Ohnmacht , U , Oakley , G , Patel , B K R , Yuen , E S M , Benhadji , K A & Rodon , J 2018 , ' First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer ' , Annals of Oncology , vol. 29 , no. 9 , pp. 1911-1917 . https://doi.org/10.1093/annonc/mdy244.  , 2018
 
?
10

tumor infiltrating lymphocytes tils and pdl1 expression as ..:

J. Martin-Liberal ; F. Pagliuca ; C. Hierro...
url:https://www.openaccessrepository.it/communities/itmirror.  , 2018
 
?
11

A phase I pharmacokinetic and safety study of cabazitaxel i..:

Azaro, A ; Rodón, J ; Machiels, J-P...
https://www.repository.cam.ac.uk/handle/1810/261646.  , 2016
 
?
12

A phase Ib dose-finding study of alpelisib (ALP; BYL719) an..:

Rodón, J ; Curigliano, G ; Delord, J-P...
info:eu-repo/semantics/altIdentifier/wos/WOS:000393912500373.  , 2016
 
?
13

A phase I pharmacokinetic and safety study of cabazitaxel i..:

Azaro, A ; Rodon, J ; Machiels, JP...
Azaro , A , Rodon , J , Machiels , JP , Rottey , S , Damian , S , Baird , R , Garcia-Corbacho , J , Mathijssen , R , Clot , PF , Wack , C , Shen , L & de Jonge , M 2016 , ' A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function ' , Cancer Chemotherapy & Pharmacology , vol. 78 , no. 6 , pp. 1185-1197 . https://doi.org/10.1007/s00280-016-3175-7.  , 2016
 
?
15

Calidad del agua de consumo en zonas urbanas y periurbanas ..:

Assandri, Matias ; Azaro, Macarena ; Orofino, Laura...
https://revistas.unlp.edu.ar/CienciasAplicadas/article/view/15874/15087.  , 2023
 
1-15